لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Miyashita M; The University of Chicago, Chicago, IL, USA., Bell JSK; Tempus Inc, Chicago, IL, USA., Wenric S; Tempus Inc, Chicago, IL, USA., Karaesmen E; Tempus Inc, Chicago, IL, USA., Rhead B; Tempus Inc, Chicago, IL, USA., Kase M; Tempus Inc, Chicago, IL, USA., Kaneva K; Tempus Inc, Chicago, IL, USA., De La Vega FM; Tempus Inc, Chicago, IL, USA., Zheng Y; The University of Chicago, Chicago, IL, USA., Yoshimatsu TF; The University of Chicago, Chicago, IL, USA., Khramtsova G; The University of Chicago, Chicago, IL, USA., Liu F; The University of Chicago, Chicago, IL, USA., Zhao F; The University of Chicago, Chicago, IL, USA., Howard FM; The University of Chicago, Chicago, IL, USA., Nanda R; The University of Chicago, Chicago, IL, USA., Beaubier N; Tempus Inc, Chicago, IL, USA., White KP; Tempus Inc, Chicago, IL, USA.; National University Singapore, Queenstown, Singapore., Huo D; The University of Chicago, Chicago, IL, USA., Olopade OI; The University of Chicago, Chicago, IL, USA. folopade@bsd.uchicago.edu.

المصدر: Breast cancer research : BCR [Breast Cancer Res] 2023 May 25; Vol. 25 (1), pp. 58. Date of Electronic Publication: 2023 May 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/ethnology , Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/ethnology , Triple Negative Breast Neoplasms*/pathology, Female ; Humans ; Black People/genetics ; Mutation ; Precision Medicine ; White People

المؤلفون: Vaklavas C; University of Alabama at Birmingham, Birmingham, AL, USA.; Present Address: Huntsman Cancer Institute, University of Utah, Salt Lake City, USA., Roberts BS; HudsonAlpha, Institute for Biotechnology, Huntsville, AL, USA., Varley KE; HudsonAlpha, Institute for Biotechnology, Huntsville, AL, USA., Lin NU; Dana-Farber Cancer Institute, Boston, MA, USA., Liu MC; Lombardi Cancer Center, Georgetown University Hospital, Washington, DC, USA., Rugo HS; University of California, San Francisco, USA.; Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Puhalla S; University of Pittsburgh Medical Center, Magee Women's Cancer Program, Pittsburgh, PA, USA., Nanda R; University of Chicago, Chicago, IL, USA., Storniolo AM; Melvin and Bren Simon Cancer Center at Indiana University, Indianapolis, IN, USA., Carey LA; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Saleh MN; Georgia Cancer Specialists PC, Atlanta, GA, USA., Li Y; University of Alabama at Birmingham, Birmingham, AL, USA., Delossantos JF; University of Alabama at Birmingham, Birmingham, AL, USA., Grizzle WE; University of Alabama at Birmingham, Birmingham, AL, USA., LoBuglio AF; University of Alabama at Birmingham, Birmingham, AL, USA., Myers RM; HudsonAlpha, Institute for Biotechnology, Huntsville, AL, USA., Forero-Torres A; University of Alabama at Birmingham, Birmingham, AL, USA. aforero@seagen.com.

مؤلفون مشاركون: Translational Breast Cancer Research Consortium (TBCRC)

المصدر: Breast cancer research : BCR [Breast Cancer Res] 2020 Feb 18; Vol. 22 (1), pp. 22. Date of Electronic Publication: 2020 Feb 18.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Breast Neoplasms/*drug therapy , Neoplasms, Hormone-Dependent/*drug therapy , Receptors, Estrogen/*metabolism , Receptors, Progesterone/*metabolism, Aged ; Aged, 80 and over ; Bevacizumab/administration & dosage ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Female ; Humans ; Letrozole/administration & dosage ; Middle Aged ; Neoplasm Staging ; Neoplasms, Hormone-Dependent/genetics ; Neoplasms, Hormone-Dependent/metabolism ; Neoplasms, Hormone-Dependent/pathology ; Postmenopause ; Receptor, ErbB-2/metabolism ; Transcriptome